Eric Lefkofsky is the co-founder of Tempus Labs based in Chicago, Illinois. He is a successful entrepreneur in his own right. Barely three years after the launch of Tempus, it has received recognition worldwide for its efforts as a healthcare startup. Tempus has partnered with the National Cancer Institute and others centers across the nation. Tempus offers a wide variety of services to cancer patients. The facilities include; cancer testing, germline DNA, RNA tumors sequencing, pathology, medical imaging, and liquid biopsy among others. Tempus has made technological advances in healthcare. This has landed it on Eric Topol’s list which features popular advances that promise to revolutionize medicine.
Tempus lab made a name for itself as one of the upcoming startups. Its use of revolutionary technology has distinguished it. It has used gene therapy and gene editing to treat ailments that were once thought terminal. Recently, Tempus developed Voretigene neparvovec-rzyl which was approved by the FDA to treat a rare form of a disease that might cause blindness. Tempus has also made advancement in skin diagnostic technology whereby it can accurately identify both malignant and benign tumors. It recently partnered with Apple to produce an ECG-apple watch that can diagnose atrial fibrillation. Tempus has also developed a pathogen sequencing device which enables physicians to come up with favorable medical responses in cases of outbreaks. It also came up with FDA approved glucose senses which can be used to dose insulin into a patient’s system directly.
Tempus has also received FDA approval for two types of drugs named Yescarta and Kymriah. Yescarta treats patients’ relapsed aggressive B-cell and Kymriah is used for pediatric and youths with refractory acute lymphoblastic leukemia.
Tempus was established in 2015.It offers extensive and analytical machine learning platform which enables physicians to provide more personalized cancer care for patients. Tempus helps physicians make calculated decisions based on real-time data generated from their genomic sequencing technology. The company aims at delivering efficient healthcare to all its cancer patients.
About Eric Lefkofsky
Lefkosky is a serial philanthropist. He has co-founded numerous tech companies such as Groupon, Uptake Technologies. He also partnered with his wife to establish the Lefkofsky Family Foundation. The foundation aims at making high impact advancements in the education, arts, culture and human rights.
For More info: www.crunchbase.com/person/eric-lefkofsky
Eric Lefkofsky is a billionaire entrepreneur and philanthropist. He has successfully founded and built a number of companies that have made a considerable impact in their respective industries. Lefkofsky is co founder of company called Tempus which is a technology firm that builds operating systems designed to fight cancer. This company has therefore been one of the more innovative organizations that has made a significant impact on the healthcare industry. Along with co founding Tempus, Eric is also the co founder and Managing Director of Lightbank which specializes in venture fund investing. During his career, he has also founded Groupon which has become a global leader in e commerce. With a number of successful businesses, Eric has established himself as one of the leading businesspeople in the United States.
As well as being a highly successful entrepreneur, Eric is also a well known philanthropist. He has provided a lot of support for a number of different causes in his community. He has founded the Lefkofsky Family Foundation which has been used to advance a number of high impact initiatives that help the communities it serves. Along with starting up Eric Lefkofsky charitable foundation, Eric also serves as a trustee of the Lurie Children’s Hospital of Chicago. He is also a trustee of the Art Institute of Chicago, The Museum of Science and the World Business Chicago. Lefkofsky is also the Chairman of the Board of Trustees of Chicago’s Steppwenwolf Theatre Company to learn more: https://www.bizjournals.com/chicago/news/2017/04/12/groupon-co-founder-moves-to-help-youth-access-art.html click here.
The educational background of Eric is also quite impressive. He attended the University of Michigan where he completed a Bachelor’s degree. Eric would later go on to attend law school at the university and eventually earn his Juris Doctor degree. During his time studying at Michigan, Eric would gain an in depth knowledge of liberal arts as well as learning about the law. This would help him in his future endeavors during his career. As a highly educated individual, Eric Lefkofsky has been able to put himself in position to apply his knowledge to all areas of his professional career. It helped him with his entrepreneurship ventures as well as allowing him to gain insight on how to best benefit the charitable organizations he has been a part of.
Seattle is home for cutting-edge research and advancements in cancer prevention and treatment. Scientists from all over the world are coming together, so as to create an enabling environment for medical research in cancer. Favorable weather conditions and availability of much needed natural resources are also factors that have contributed to Seattle’s suitability as a home for medical research.
In Seattle, you cannot miss the footprint of one experienced professional known as Clay Siegall. He is one of the best therapeutic and cancer research experts. He derives satisfaction from discovering treatments to many ailments that affect most people, saving families and insurance funds millions of dollars in medical treatment. Dr. Clay Siegall is devoted to ensuring that effective cancer treatment is achieved soon.
Clay Siegall has had a decorated career in medicine. He started with an education from the University of Zoology in Maryland. Later, he earned a Ph.D. from the University of George Washington. He served in different roles at both the National Cancer Institute and the Bristol-Meyers Squibb Pharmaceutical Research Institute.
Seattle Genetics company is Clay Siegall’s brainchild. He is the enterprise’s research board director. He is the serving board director at Alder Biopharmaceuticals, Fred Hutchinson Cancer Research Business Alliance, and the American Biomedical Association.
Seattle Genetics is devoted to finding solutions that can cure cancer and other immune system diseases. Dr. Clay is driven by passion and the urge to help people suffering from cancer and other autoimmune diseases. Through research and innovation, he has been able to come up with drugs that specifically target cancerous body cells without affecting healthy body cells.
Dr. Clay founded Seattle Genetics with the aim of helping patients access less invasive but effective medication as well as providing vital information for drug development. Dr. Clay has continuously worked to develop medical products for curing cancer, and other diseases affecting the human immune system.
Existing cancer treatments are too destructive. Most drugs destroy cancer cells but at the same time affect the body’s immune system, leaving the body more vulnerable to other disease attacks. It is through interventions like those of Clay Siegall that patients can restore their hope in winning the battle against cancer.